« BACK

Medicine/Pharmacology



Results 1 - 20 of 9750.
1 2 3 4 5 ... 488 Next »

Medicine/Pharmacology - Life Sciences
16.02.2018
Regional brain shrinkage in MS predicts disability
Regional brain shrinkage in MS predicts disability
A UCL-led research team has identified the pattern of brain tissue loss in multiple sclerosis, enabling improved prediction of disability progression. The study, published in Annals of Neurology , was one of the largest brain imaging studies ever conducted investigating multiple sclerosis (MS). "It's well known that brain atrophy occurs in people with MS and varies by region, but we typically only measure the shrinkage of the whole brain.
Life Sciences - Medicine/Pharmacology
16.02.2018
New approaches in neuroscience show it’s not all in your head
Our own unique experiences shape how we view the world and respond to the events in our lives. But experience is highly subjective. What's distressing or joyful to one person may be very different to another. These differences can matter, especially as a growing body of research shows that what happens in our inner landscapes - our thoughts about and interpretations of our experiences - can have physical consequences in our brains and bodies.
Medicine/Pharmacology
16.02.2018
Novartis new data show Cosentyx improved quality of life over 5 years in two thirds of patients with moderate to severe plaque psoriasis
Two thirds of patients on Cosentyx (secukinumab) reported no impact of skin disease on their quality of life over 5 years, SCULPTURE study shows Findings show absolute PASI <=1/<=2/<=3 responses were sustained in those treated with Cosentyx from Year 1 to Year 5 Cosentyx is the first and only fully human interleukin-17A (IL-17A) inhibitor that showed sustained skin clearance rates at 5 years in patients from a psoriasis Phase III st
Medicine/Pharmacology - Life Sciences
15.02.2018
UCL cancer trials to get £9m funding boost
UCL cancer trials to get £9m funding boost
Cancer Research UK is planning to invest nearly 9m over the next five years into research at the Cancer Research UK & UCL Cancer Trials Centre. The announcement is part of a 45 million investment into Cancer Research UK's network of clinical trials units across the UK, one of the charity's largest investments in clinical research to date.
Life Sciences - Medicine/Pharmacology
15.02.2018
Secrets behind the cuttlefish's 3D 'invisibility cloak'
Secrets behind the cuttlefish’s 3D ’invisibility cloak’
An international team of scientists has identified the neural circuits that enable cuttlefish to change their appearance in just the blink to eye - and discovered that this is similar to the neural circuit that controls iridescence in squids. The sea is full of strange and wondrous creatures, but there are few as bizarre and intelligent as octopuses and cuttlefish.
Life Sciences - Medicine/Pharmacology
15.02.2018
CRISPR scissors, Cas12a, enables cutting-edge diagnostics
CRISPR-Cas12a, one of the DNA-cutting proteins revolutionizing biology today, has an unexpected side effect that makes it an ideal enzyme for simple, rapid and accurate disease diagnostics. Cas12a, discovered in 2015 and originally called Cpf1, is like the well-known Cas9 protein that UC Berkeley's Jennifer Doudna and colleague Emmanuelle Charpentier turned into a powerful gene-editing tool in 2012.
Life Sciences - Medicine/Pharmacology
15.02.2018
Amyloid protein transmission through neurosurgery
Amyloid protein transmission through neurosurgery
Amyloid beta pathology - protein deposits in the brain - might have been transmitted by contaminated neurosurgical instruments, suggests a new UCL-led study. For the paper, published today in Acta Neuropathologica , researchers studied the medical records of four people who had brain bleeds caused by amyloid beta build-up in the blood vessels of the brain.
Life Sciences - Medicine/Pharmacology
15.02.2018
Researchers advance CRISPR-based tool for diagnosing disease
Researchers advance CRISPR-based tool for diagnosing disease
The team that first unveiled the rapid, inexpensive, highly sensitive CRISPR-based diagnostic tool called SHERLOCK has greatly enhanced the tool's power, and has developed a miniature paper test that allows results to be seen with the naked eye - without the need for expensive equipment. The SHERLOCK team developed a simple paper strip to display test results for a single genetic signature, borrowing from the visual cues common in pregnancy tests.
Medicine/Pharmacology
15.02.2018
Study suggests expanded range for emerging tick-borne disease
Human cases of Borrelia miyamotoi , a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health strongly suggests that the pathogen's geographic range is bicoastal, far larger than previously believed.
Medicine/Pharmacology - Innovation/Technology
15.02.2018
Improving Health of Children in Nigeria
To improve diagnosis and treatment of children under five, Swiss TPH together with the International Committee of the Red Cross (ICRC) developed the electronic decision support tool ALMANACH.
Agronomy/Food Science - Medicine/Pharmacology
14.02.2018
Food deserts not to blame for growing nutrition gap between rich and poor, study finds
For decades, the conventional wisdom has been that people living in food deserts-defined as areas lacking in supermarkets with fresh produce and other nutritious items-have little choice but to buy unhealthy food at drugstores or convenience stores. But the data tell a different story. A new Chicago Booth study finds that food deserts have no meaningful effect on eating habits.
Medicine/Pharmacology - Life Sciences
14.02.2018
What is your real ’biological age’-
Having an older biological age on aged-based risk calculators simply means you have at least one risk factor that is higher than the number set as "normal", writes Dr Carissa Bonner from the School of Public Health. Age-based risk calculators that work out your "real biological age" are increasingly popular.
Medicine/Pharmacology - Life Sciences
14.02.2018
Brain scan and artificial intelligence could help predict whether OCD will improve with treatment
Brain scan and artificial intelligence could help predict whether OCD will improve with treatment
Washing hands needlessly dozens of times of day. Spending so much time perfecting schoolwork that it never gets turned in. These are typical behaviors for people with obsessive compulsive disorder, or OCD, a lifelong illness marked by repetitive thoughts and actions that can seriously impair work performance, relationships and quality of life.
Medicine/Pharmacology - Life Sciences
14.02.2018
Meet RIPK3: Good Cop, Bad Cop, all in one
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37children have diedin the United States during the current fluseason. Aside from getting the flu shot and employing smart hand hygiene, there are no other methods of prevention.
Medicine/Pharmacology - Life Sciences
13.02.2018
Newly discovered gene may protect against heart disease
Newly discovered gene may protect against heart disease
Scientists have identified a gene that may play a protective role in preventing heart disease. Their research revealed that the gene, called MeXis, acts within key cells inside clogged arteries to help remove excess cholesterol from blood vessels. Published Medicine, the UCLA-led study in mice found that MeXis controls the expression of a protein that pumps cholesterol out of cells in the artery wall.
Medicine/Pharmacology - Physics/Materials Science
13.02.2018
Light-activated cancer drugs without toxic side effects: fresh insight
Cancer drugs activated by light, minimizing toxic side-effects, are a step closer thanks to new research from University of Warwick and Monash University through the Monash Warwick Alliance.
Medicine/Pharmacology
13.02.2018
North-south divide revealed as prescription of opioid drugs rise
The prescription of opioid drugs by GPs in England is steadily rising, especially in more deprived communities, even though they can cause complications and adverse effects and do not work for chronic pain, a UCL study has revealed. The study, led by Dr Luke Mordecai, a pain research fellow at University College London Hospital (UCLH) found that over a 43 month period between 2010 and 2014 there was a rise in opioid prescribing.
Medicine/Pharmacology - Life Sciences
13.02.2018
'Off the shelf' living artificial tissues could repair severe nerve injuries
’Off the shelf’ living artificial tissues could repair severe nerve injuries
Severe nerve damage has been successfully repaired in the laboratory using a new living artificial nerve tissue developed by UCL, ReNeuron and Sartorius Stedim Biotech.
Life Sciences - Medicine/Pharmacology
12.02.2018
Scientists develop low-cost way to build gene sequences
Scientists develop low-cost way to build gene sequences
A new technique pioneered by UCLA researchers could enable scientists in any typical biochemistry laboratory to make their own gene sequences for only about $2 per gene. Researchers now generally buy gene sequences from commercial vendors for $50 to $100 per gene. The approach, DropSynth, which is described in the January issue of the journal Science, makes it possible to produce thousands of genes at once.
Medicine/Pharmacology - Chemistry
12.02.2018
Lung cancer drug resistance explained by computer simulations
Lung cancer drug resistance explained by computer simulations
Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer. Osimertinib binds tightly to a protein, epidermal growth factor receptor (EGFR), which is overexpressed in many tumours.
1 2 3 4 5 ... 488 Next »